Navigation Links


Bipolar in Medical Technology

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... of manic or mixed episodes associated with bipolar I disorder in adults and in favor of use in acute ... unmet need for patients with schizophrenia and bipolar I disorder, including patients starting treatment ... and safe (12/0/0 and 10/0/2) for the bipolar I disorder and schizophrenia indications, ...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... or manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old. ... for manic or mixed episodes associated with bipolar I disorder, the panel voted 17-0, with one ... of Zyprexa in adolescents with schizophrenia or bipolar I disorder, including a six-week double-blind, ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... to relapse compared to placebo in patients with bipolar I Disorder. Results of the study were presented this week at a major medical meeting. bipolar Disorder is a brain disorder that causes unusual ... (mania) to extreme lows (depression). Type I bipolar Disorder is characterized based on the occurrence ...

Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression

... treating major depressive disorder in adults with bipolar I disorder. An estimated two million American adults are affected by bipolar I disorder, which is characterized by ... and lows (depressed) in mood. People with bipolar disorders cycle between periods of manic or ...

Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder

... to identify what factors make some people with bipolar depression more likely to experience treatment-emergent mania (TEM). bipolar disorder, also known as manic-depressive illness, ... earlier study led by Robert Post, M.D., and the bipolar Collaborative Network. In that earlier study, ...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... various patient populations including depression, bipolar disorder, Alzheimer's disease, mild cognitive ... many neuropsychiatric (e.g. major depression, bipolar disorder, PTSD, mild cognitive impairment and ... disruption is common in patients with depression, bipolar disorder and other mood disorders, Alzheimer's ...

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

... schizophrenia, acute mixed and manic episodes of bipolar I disorder, and maintenance treatment of bipolar disorder. Olanzapine is not approved for ... placebo-controlled, short-term schizophrenia and bipolar mania trials was somnolence. Other common events ...

Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial

... 3 clinical trial was conducted in patients with bipolar disorder experiencing acute agitation. Both the ... including schizophrenia and bipolar disorder. Patients experiencing agitation become ... afflicts about 2.5 million adults and bipolar disorder affects about 6 million adults. The ...

Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder

... in patients with acute mania associated with bipolar I disorder. For the primary endpoint, the Young ... exciting preliminary results in patients with bipolar mania demonstrate the potential of cariprazine as ... patients with acute mania associated with bipolar I disorder. During the five week study, 236 men ...

Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients

... acute agitation in patients with schizophrenia or bipolar disorder. AZ-004 is being developed ... believes that many patients with schizophrenia or bipolar disorder can make informed decisions ... initiated a second Phase 3 clinical trial in bipolar disorder patients with acute agitation. About ...

Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates

... treatment of acute agitation in schizophrenic or bipolar disorder patients," said Thomas B. King, ... enroll approximately 300 patients diagnosed with bipolar I disorder and acute agitation at 18 U.S. ... This study is the first AZ-004 study enrolling bipolar disorder patients. The Company projects that this ...

Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

... acute agitation in patients with schizophrenia or bipolar disorder. Alexza believes the novel, non-invasive ... enroll approximately 300 patients diagnosed with bipolar I disorder and acute agitation at 18 U.S. ... believes that many patients with schizophrenia or bipolar disorder can make informed decisions ...

Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference

... acute mixed and manic episodes of bipolar disorder, and maintenance treatment of bipolar disorder. In Europe, olanzapine is indicated for ... for the prevention of recurrence in patients with bipolar disorder. Since olanzapine was introduced in ...

Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder

... Gary S. Sachs, M.D., founder and director of the bipolar Clinic and Research Program at the Massachusetts ... 2a clinical trial of RG2417 in patients with bipolar disorder. We have now completed our assessment of ... reflect the difficulty in accurately diagnosing bipolar disorder in the absence of frequent ...

NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression

... illnesses, such as schizophrenia, bipolar disorder and depression. To be presented at ... susceptibility to and pathology of schizophrenia, bipolar disorder and depression, some of the most severe, ... are carriers of the genes for schizophrenia and bipolar disorder, even though these individuals don't ...

Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

... treatment of schizophrenia and bipolar I disorder WASHINGTON, May 8 ... Data from the studies, involving patients with bipolar I disorder and schizophrenia, were presented in ... was shown to be effective in two short-term bipolar mania studies with a nine-week extension and in ...

New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

... of quetiapine is approved for the treatment of bipolar depression. (See Boxed Warning.) Hyperglycemia, ... in MDD is similar to a depressive episode of bipolar disorder with the major distinguishing feature ... been reported that 69 percent of patients with bipolar disorder were misdiagnosed, with the most ...

UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials

... president of the International Society of bipolar Disorder (ISBD). -- Cyril Hoschl, MD, DSc., ... Professor of Psychiatry and Director of the bipolar Disorders Program of the Hospital Clinic at the ... of Neuroscience and he currently leads the bipolar Research Program at the Spanish Research Network ...

Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release

... of the seriousness of schizophrenia or bipolar disorder, no reference to the importance of ... schizophrenia, acute mixed and manic episodes of bipolar I disorder, and maintenance treatment of bipolar disorder. Since Zyprexa was introduced in 1996, ...

Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache

... acute agitation in patients with schizophrenia or bipolar disorder. AZ-004 and AZ-104 are being developed ... acute agitation in patients with schizophrenia or bipolar disorder. About Symphony Allegro In December ... treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)

... of manic and mixed episodes associated with bipolar I Disorder, with or without psychotic features in ... of manic and mixed episodes associated with bipolar I Disorder with or without psychotic features in ... 2004 and March 2005, respectively. "Pediatric bipolar illness is a serious condition," said ...

Positive Results Published Using AtriCure Minimally Invasive Products

... procedure using the AtriCure minimally invasive bipolar ablation system. Additionally, in 21 of the 22 ... surgeons of the AtriCure Isolator(R) bipolar ablation clamps as a treatment alternative during ... The FDA has cleared the AtriCure Isolator(R) bipolar ablation system, including the new Isolator ...

AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

... the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder. The bipolar mania submission is based on a clinical study of ...

Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA

... and acute mania or mixed episodes associated with bipolar I Disorder. In accepting the NDA, the FDA ... Organon BioSciences on November 19, 2007. About bipolar Disorder bipolar Disorder, commonly referred to as ...

SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia

... in 77 countries for the treatment of bipolar mania, and in 11 countries including the U.S. for the treatment of bipolar depression. SEROQUEL XR was launched for the ... for the treatment of depressive episodes in bipolar disorder; acute manic episodes ...

Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder

... and efficacy of RG2417 on the symptoms of bipolar depression as measured by the co-primary ... of funding for research on schizophrenia and bipolar disorder in the United States. "We are pleased ... in the design of future clinical studies." About bipolar Disorder ...

Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder

... for children and adolescents diagnosed with bipolar disorder," said Robert A. Kowatch, M.D., Ph.D., a ... acute efficacy results from the Pediatric bipolar Collaborative Mood Stabilizer Trial, which also ... for another 16 weeks. The classic form of the bipolar illness, also know ...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

... for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. The Company projects an NDA submission for AZ-004 in the first ... being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

... schizoaffective disorder is sometimes misdiagnosed as schizophrenia or bipolar disorder. For patients who frequently use mental health services, ... markets prescription medications for the treatment of schizophrenia, bipolar mania and the treatment of symptoms associated with autistic disorder. ...

Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

... that supports research on the causes and treatment of schizophrenia and bipolar disorder (manic-depressive illness), both through work carried out in its ... has provided over $200 million in funding since 1989. Schizophrenia and bipolar disorder are major psychiatric disorders in the United States, affecting ...

Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches

... for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. The Company has previously announced positive results in two ... being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive initial ...

U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder

... and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy. The action letter includes proposed ... trial program involving more than 3,000 patients in schizophrenia and bipolar mania trials. Schering-Plough is an innovation-driven, ...

Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention

... of schizophrenia, and treatment of manic episodes associated with bipolar 1 disorder. Asenapine is currently under review by the U.S. Food and Drug ... of schizophrenia and acute manic or mixed episodes associated with bipolar I disorder. The company acquired asenapine in November 2007 through its ...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

... disorder can be difficult to distinguish from schizophrenia or bipolar disorder because the symptoms are similar to both. The disorder is about ... markets prescription medications for the treatment of schizophrenia, bipolar mania and the treatment of symptoms associated with autistic disorder. For ...

Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation

... be similar to the first trial, except that the patient population will be bipolar disorder patients. Conference Call Information The Company will host ... loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato ...

Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder

... the treatment of acute agitation in patients with schizophrenia or bipolar disorder. Alexza will host an investor conference call to discuss today's ... loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato ...

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines

... adult patients. SEROQUEL XR is currently not approved for the treatment of bipolar disorder. In January 2008, AstraZeneca announced the submission of two ... an immediate release form of quetiapine is approved for the treatment of bipolar depression. (See Boxed Warning.) Hyperglycemia, in some cases extreme ...

Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status

... the first trial, except that the patient population will be patients with bipolar disease. AZ- 004 is being developed through Symphony Allegro, a product ... loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato ...

Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders

... given last week at the 14th Biennial Winter Workshop on Schizophrenia and bipolar Disorders. ITI-007 is currently in Phase I clinical trials for the ... modulation for antipsychotic maintenance therapy and the treatment of bipolar disorders. ITI-007 has a much lower propensity than several currently ...

FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

... mixed and manic episodes of bipolar disorder, and maintenance treatment of bipolar disorder. Since Zyprexa was introduced in 1996, it has been prescribed to ... with Zyprexa in placebo-controlled, short-term schizophrenia and bipolar mania trials was somnolence. Other common events were dizziness, weight ...
Other Contentsrhabdomyosarcomarheumatismrheumatoidrheumatoidrheumatoidrheumatoidrheumatoidrheumatoidricketsricketsricin
(Date:11/24/2009)...entists have crystallised a protein that may help ...he protein could be used by probiotic producers to...nefit to people. , "Probiotics need to interact w...ct, and if they attach to surfaces in the gut they...ert their activity," says Dr Nathalie Juge from th...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The W... a report revealing that the last remaining popula...icantly due to the rising tide of poaching and hab...l help inform Russian officials of what needs to b...ld,s biggest cat. , The report was ...
(Date:11/24/2009)...is release is available in Spanish . , The ...er levels of inflammatory substances in the blood,...as shown by a research project of the University o... scientist at the School of Pharmacy. , The proj...dy in relation to the control of body weight and i...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Cocaine Addiction Vaccine Shows Some Success 58894 1Cocaine Addiction Vaccine Shows Some Success 58894 2Cocaine Addiction Vaccine Shows Some Success 58894 3VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 1Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 2Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 3
(Date:11/27/2009)...Consideredahighlyriskyandcontroversialmedicalproce...life-savingmainstreamoperationthankstotheextraordi...nDallasonNov.11.Leaderscametogetherfrommedicalcent...ylorRegionalTransplantInstitute(BRTI),oneofthepion... Itwas25yearsagothatBaylorHealthCareSystemchosetop...
(Date:11/27/2009)...27 Team Garmin-Slipstream, the eli... ethical sporting and developing the next generati...ill become Team Garmin-Transitions with the additi...team. Transitions Optical is the world,s leading m... advanced photochromic technology in the widest se...
(Date:11/27/2009)... may reduce future disease burden, researchers say... Encouraging city dwellers to walk and bicycle ins... health benefits than increased used of low-emissi... study compared the projected health effects in 20...or London, England, and Delhi, India: business-as...
(Date:11/27/2009)... announced today that Spectrum Health (Grand Rapid... orthopedic templating solution and its TraumaCad ... (PRWEB) November 27, 2009 -- Voyant Health&trad...ids, Michigan) has licensed its TraumaCad Enterpri...d Extend workflow solution, to allow its orthopedi...
(Date:11/27/2009)...e anatomy education apps from Modality and Lippinc...learning opportunities for iPhone and iPod touch ...ber 27, 2009 -- Modality, Inc. and Lippincott Wi...Kluwer Health, today announced the availability of.... Clemente’s Anatomy, Rohen’s Photogra...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
Other TagsTrephineCastroviejoImpairedDraftSwansOther Tagsstraight 2straight 3straight 4straight 5straight 6incorporate 2incorporate 3incorporate 4incorporate 5chilled 2products 2products 3products 4products 5products 6products 7products 8products 9products 10eliminate 2eliminate 3eliminate 4eliminate 5eliminate 6eliminate 7eliminate 8reduce 2reduce 3reduce 4reduce 5reduce 6reduce 7reduce 8reduce 9reduce 10pet 2